November 18, 2026

Cotton, Klobuchar Bill to Establish Biosecurity Requirements Passes Senate Commerce Committee

FOR IMMEDIATE RELEASE
Contact: Tatum Wallace or Hannah McCarthy 
November 18, 2026

Cotton, Klobuchar Bill to Establish Biosecurity Requirements Passes Senate Commerce Committee

WASHINGTON—Senator Tom Cotton (R-Arkansas) and Senator Amy Klobuchar (D-Minnesota) released the following statements after the U.S. Senate Committee on Commerce, Science, and Transportation passed their Biosecurity Modernization and Innovation Act, which would require gene synthesis providers to screen their orders and customers to ensure bad actors aren’t ordering dangerous sequences.

“The federal government must ensure Americans are protected from biosecurity threats posed by terrorists and bad actors who seek to do us harm. I’m pleased my bipartisan Biosecurity Modernization and Innovation Act passed the Senate Commerce Committee, bringing it one step closer to becoming law,” said Senator Cotton.

“While access to genetic material allows scientists to study diseases, develop lifesaving medicine, and improve crops, without safety standards it could be misused, including to create bioweapons. Our bipartisan legislation will enhance biosecurity efforts and reduce the risk of genetic material being used to cause harm by ensuring that the companies selling these products know who their customers are and how they will use genetic material,” said Senator Klobuchar.

The Biosecurity Modernization and Innovation Act is endorsed by the National Security Commission on Emerging Biotechnology, the Engineering Biology Research Consortium, Twist Bioscience, Aclid, Integrated DNA Technologies (IDT), Ginkgo Bioworks, OpenAI, Microsoft, Google DeepMind, and Anthropic, along with broad support among biosecurity and biotechnology policy researchers.

###

Print 
Email 
Share 
Share